CEACAM5 and cancer: A study showed that serum CEA level could be a predictive factor for the efficacy of gefitinib treatment (a drug that is used to treat non-small cell lung cancer also is being studied in the treatment of other types of cancer) while also considering CEA a prognostic factor for advanced non-small cell lung cancer patients undergoing this treatment (Okamoto et al. 2005).